Injection sclerotherapy for varicose veins

2021 ◽  
Vol 2021 (12) ◽  
Author(s):  
Ricardo de Ávila Oliveira ◽  
Rachel Riera ◽  
Vladimir Vasconcelos ◽  
Jose CC Baptista-Silva
2014 ◽  
Vol 30 (10) ◽  
pp. 729-735 ◽  
Author(s):  
L Jones ◽  
K Parsi

Ultrasound guided sclerotherapy may be complicated by intra-arterial injections resulting in significant tissue necrosis. Here, we present a 69-year-old man with a history of right small saphenous vein “stripping”, presenting for the treatment of symptomatic lower limb varicose veins. Duplex ultrasound of the right lower limb outlined the pathway of venous incompetence. Despite the history of “stripping”, the small saphenous vein was present but the sapheno-popliteal junction was ligated at the level of the knee crease. No other unusual findings were reported at the time. During ultrasound guided sclerotherapy, subcutaneous vessels of the right posterior calf were noted to be pulsatile on B-mode ultrasound. Treatment was interrupted. Subsequent angiography and sonography showed absence of the right distal popliteal artery. A cluster of subcutaneous vessels of the right medial and posterior calf were found to be arterial collaterals masquerading as varicose veins. Injection sclerotherapy of these vessels would have resulted in significant tissue loss. This case highlights the importance of vigilance at the time of treatment and the invaluable role of ultrasound in guiding endovenous interventions.


1986 ◽  
Vol 1 (3) ◽  
pp. 217-220 ◽  
Author(s):  
P. Reddy ◽  
J. Wickers ◽  
T. Terry ◽  
P. Lamont ◽  
J. Moller ◽  
...  

Two consecutive randomized trials following injection sclerotherapy for varicose veins compared 3 and 6 weeks bandaging in 148 patients and 1 to 3 weeks bandaging in 130 patients. Objective assessment and patient's symptoms, using a scoring system, correlated well and showed that there was no difference whatsoever between 3 and 6 weeks' bandaging after a 6 year follow-up. In the second trial, the patients who were bandaged for 3 weeks were significantly better (P < 0.001) than after only one week of bandaging at a maximum follow up of 4 years. Long term follow up of injection sclerotherapy for primary varicose veins suggests that 3 weeks is superior to 1 week bandaging, but that there is no additional advantage in continuing bandaging for six weeks.


Phlebologie ◽  
2010 ◽  
Vol 39 (04) ◽  
pp. 202-207
Author(s):  
K. Denk ◽  
D. Schliephake ◽  
A. Recke ◽  
B. Kahle

SummaryIn clinical practice sclerotherapy of intradermal varicose veins seems to be more effective in elderly patients. Patients, methods: After prior duplex-sonographic investigation 48 patients with intradermal varicose veins (diameter 1–2 mm, C1,EP, AS, PR) were included. 24 patients (group 1) received Polidocanol (0.25% Aethoxysklerol®) injection sclerotherapy and 24 patients (group 2) received sodium chloride injections. In all subjects an area of 100 square centimetres of the lower limb was treated. The borders of each area were marked and photo documented. The injections were performed by an examiner who was unaware of which liquid had been injected. Compression therapy was performed for one week after the treatment. One and four weeks later the results were controlled by the physician who performed the injections and documented by an independent photographer. The glossy prints of the areas before and four weeks after the treatment were sent to two blinded independent external reviewers. The reviewers noted their evaluation on a visual analogue scale (VAS). The reviewers received each anonymous photodocument twice within 3 weeks. Results: The VAS of both experts showed a significant difference between the results in group 1 and group 2 (p < 0.0001). Median of efficacy was 58.5% in group 1 (verum) and 0.5% in group 2 (placebo). Both experts had a stable intraindividual reliability of 85% and further both raters didn´t differ concerning their ratings. In group 1 (verum) the Pearson correlation coefficient showed a significant correlation between the therapeutic outcome and the age of the treated patients. Conclusions: Injection sclerotherapy of intradermal varicose veins using 0.25 %Polidocanol (Aethoxysklerol) is an efficient treatment that leads to a good aesthetic outcome. In elderly patients sclerotherapy is more efficient.


1997 ◽  
Vol 14 (1) ◽  
pp. 71-73
Author(s):  
Jose A. Olivencia

The physiologic importance of varicose veins and resulting morbidity has been well established since the 18th Century. However, venous disorders have aroused very little interest in the medical community. New options in the treatment of varicose veins are effective, cosmetically pleasing, and convenient for the patient. Venous disorders represent a significant source of morbidity worldwide. Relatively painless, low-risk outpatient treatments have proven to be effective. These treatments include a combination of surgical removal, ambulatory phlebectomy, and injection sclerotherapy. A review of the history, anatomy, pathophysiology, and diagnosis of venous disorders, including new trends in treatment protocols, is discussed.


2015 ◽  
Author(s):  
Mikel Sadek ◽  
Victoria Lee ◽  
Lowell S. Kabnick

Closure of incompetent superficial veins via endovenous techniques has become the standard of care for treatment of patients with chronic venous insufficiency and symptomatic varicose veins. The safety and efficacy of these procedures have been supported by the peer-reviewed literature, and these procedures have largely replaced the surgical treatments of high ligation and stripping. Three major developments have led to the current endovenous techniques: laser and radiofrequency catheters that deliver thermal energy, tumescent anesthesia, and duplex ultrasonography. This review covers relevant anatomy, pathophysiology, clinical signs and symptoms, diagnostics, treatment, tumescentless therapy, ClariVein (mechanochemical ablation), and the VenaSeal Closure System. Figures show telangiectasias, reticular veins, varicose veins, edema/swelling, hyperpigmentation, venous stasis ulcers, the ClosureFast Catheter, access using the great saphenous vein proximal to the popliteal region, application of tumescent anesthesia, segmental ablation using the ClosureFAST system, the NeverTouch Direct Procedure Kit by AngioDynamics, Varithena foam sclerosant, the ClariVein Occlusion Catheter, and the VenaSeal Sapheon Closure System. Tables list perforating veins of the lower extremity, Clinical, Anatomic, Etiologic, Pathophysiologic classification, and the Venous Clinical Severity Score. This review contains 12 figures, 3 tables, and 103 references


Phlebologie ◽  
2014 ◽  
Vol 43 (05) ◽  
pp. 257-261
Author(s):  
R. K. Miyake

SummaryBackground: This study is about CLaCS, a new technique to treat telangiectasias and feeder veins.Method: A series of 140 cases were treated under Augmented Reality guidance in a completely different way. Sclerosis was achieved by combination of thermal and chemical agents: laser and dextrose. Patients were classified according to two questions: presence of varicose veins and/or reflux on the saphenous vein; presence of telangiectasias and/or feeder veins (Score 9–1). Duplex ultra-sound and Augmented Reality (VeinViewer) were used to detect reflux and feeder veins, respectively. Feeder veins and telangiectasias were treated the same way, in the same procedure, by a combination of Nd:YAG 1064 nm with spot sizes of 6mm, 15 msec pulse and fluence of up to 80 J/cm2 followed by injection sclerotherapy of Dextrose 75%. Both techniques were done under forced air skin cooling (Cryo5). A thorough photodocumentation was done prior and after each procedure and results were obtained by comparing before and after photos on two iPads. Response to the treatment was rated on: total or partial improvement with patient satisfaction (Group 1); partial improvement or lack of resolution, without patient satisfaction (Group 2).Results: A total of 466 patients visited the clinic during the study and exclusion criteria left a total of 140 patients for analysis. Mean age of patients was 37 years (16 to 72), with prevalence of women (98 %). No allergic reactions, systemic reactions, skin burns, post-sclerotherapy mattings, infections or crustings were observed. Temporary ecchymosis were observed in 30 % of the cases, and intravenous coagula in 14 % of them. No frostbite was registered due to cold air blowing. Partial or total lesion improvement was obtained in 121 patients (86 %), with satisfactory cosmetic results. Unsatisfactory outcome was observed in 19 patients (14 %) due to no response or lesion worsening, thus crochet hook phlebectomy was indicated.Conclusion: CLaCS guided by Augmented Reality is a very effective option to treat telangiectasias, reticular and feeder veins. It is a safe method based on the employment of technology and an organic sclerosing agent. It dispenses the use of any other medication, thus being free of risk of anaphylaxis or embolism.


1998 ◽  
Vol 13 (1) ◽  
pp. 31-35 ◽  
Author(s):  
P. J. Kent ◽  
M. J. Weston

Objective: The aim of this study was to determine whether an increased body mass index should influence the choice of continuous-wave Doppler probe frequency in the clinical assessment of patients with varicose veins. Design: Prospective assessment of the effect of raised body mass index on the accuracy of clinical assessment of venous reflux using 4 and 8 MHz Doppler probes compared with duplex scanning. Setting: The ultrasound department of a university teaching hospital. Patients: Seventy-two patients with symptomatic primary varicose veins (108 limbs), who had not undergone previous injection sclerotherapy or surgical treatment. Main outcome measures: Measurement of body mass index and assessment of reflux with hand-held Doppler using 4 and 8 MHz probes immediately followed by duplex scanning. Results: There was no significant difference between the 4 and 8 MHz Doppler probes in the accuracy of detection of reflux at the sapheno-femoral junction, in the long saphenous vein or at the sapheno-popliteal junction in the whole patient group or in the obese subgroup. Conclusion: Body mass index should not influence the choice of probe frequency (between 4 and 8 MHz) in the clinical assessment of patients with primary previously untreated varicose veins.


BMJ ◽  
1976 ◽  
Vol 2 (6038) ◽  
pp. 725-727 ◽  
Author(s):  
P H Fentem ◽  
M Goddard ◽  
B A Gooden ◽  
C K Yeung

Sign in / Sign up

Export Citation Format

Share Document